bf/NYSE:ABBV_icon.jpeg

NYSE:ABBV

AbbVie Inc.

  • Stock

USD

Last Close

219.04

06/11 22:24

Market Cap

296.91B

Beta: 0.55

Volume Today

5.82M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

    Description

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients;...Show More

    Earnings

    Earnings per Share (Estimate*)

    12342017-04-272019-04-252021-04-302023-04-272024-10-25

    Revenue (Estimate*)

    5B10B15B2017-04-272019-04-252021-04-302023-04-272024-10-25

    *Estimate based on analyst consensus